AntriaBio Inc Share Price OTC Bulletin Board
Equities
US0372301095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
06-05 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
06-05 | Sector Update: Health Care | MT |
Sales 2024 * | - | Sales 2025 * | 20.55M 1.61B | Capitalization | 230M 18.03B |
---|---|---|---|---|---|
Net income 2024 * | -63M -4.95B | Net income 2025 * | -53M -4.16B | EV / Sales 2024 * | - |
Net cash position 2024 * | 86M 6.76B | Net cash position 2025 * | 68M 5.34B | EV / Sales 2025 * | 7.86 x |
P/E ratio 2024 * |
-4.66
x | P/E ratio 2025 * |
-6.18
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.6% |
Latest transcript on AntriaBio Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 25/07/10 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 25/07/10 |
Daron Evans
DFI | Director of Finance/CFO | 50 | 01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 25/07/10 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 09/02/19 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 19/11/19 |
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |